Skip to NavigationSkip to content

Recipharm commences new supply contract and completes purchase of facility in Spain

Published date: 

Recipharm AB announces that it has today commenced the supply of commercial products to Roche and completed the acquisition of the manufacturing facility located in Leganés, Spain.

Thomas Eldered, CEO of Recipharm commented: “We are continuing to gain momentum in the CDMO market and this latest agreement is another demonstration of this. I welcome our new colleagues in Spain and look forward to providing Roche with first-class CDMO services”. 

Contact information
Thomas Eldered, CEO, telephone: +46 8 602 52 10
Henrik Stenqvist, CFO,, telephone: +46 8 602 52 00

This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 1 December 2017, at 13:00 CET. 

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches